slip sliding away......., page-9

OOps, and I mean a big OOps,
yes I believe we have NOT seen where this one can go.
Have a look at Shaws and other brokers tracking NAl for their insights.
If the float, if successful is worth the $60-$70m proposed or even 2/3rds of that, then we see a very low capitalisation placed on the other products such as LADS, which in the early part of last year was the reason people got to know of NAL.
There will be releases in the near future as to the successes of LADS post the various seminars in the US and usage in US hospitals which will ramp the interest again.